Buy dapoxetine is indicated for the treatment of premature ejaculation (PE) in adult men aged 18-64 years.
Dapoxetine should only be prescribed to patients who meet all of the following criteria:
intravaginal ejaculation latency time (IELT) less than two minutes,
Ejaculation which, permanently or recurrently, occurs with minimal sexual stimulation, before, during or shortly after penetration and before the patient wishes,
Significant personal suffering or interpersonal difficulties as a consequence of PE,
poor control of ejaculation,
· A history of premature ejaculation in the majority of sexual intercourse in the last 6 months.
PRILIGY should only be administered as an on-demand treatment prior to planned sexual activity.
PRILIGY should not be prescribed to delay ejaculation in men who have not been diagnosed with PE.
How to take Dapoxetine
Adult males (aged 18-64)
The recommended starting dose for all patients is 30 mg taken as needed approximately 1 to 3 hours before sexual activity. Treatment with PRILIGY should not be initiated at a dose of 60 mg.
PRILIGY is not intended for continuous daily use. PRILIGY should be taken only when sexual activity is anticipated. PRILIGY should not be taken more than once in 24 hours.
If individual response to 30 mg is insufficient and the patient has not experienced moderate or severe adverse reactions or potential prodromal symptoms suggestive of syncope, the dose may be increased to a maximum recommended dose of 60 mg, taken as needed approximately 1 3 hours before sexual activity.The incidence and severity of adverse events are higher with the 60 mg dose.
If the patient experienced orthostatic reactions at the initial dose, no dose increase to 60 mg should be performed (see section 4.4).
A careful assessment of the individual risk benefit of PRILIGY should be performed by the physician after the first four weeks of treatment (or at least after 6 doses of treatment) to determine whether continued treatment with PRILIGY is appropriate.
Data on the efficacy and safety of PRILIGY beyond 24 weeks are limited. The clinical need to continue and the balance of benefit-risk of treatment with PRILIGY should be reassessed at least every six months.
Elderly (65 years and over)
The efficacy and safety of PRILIGY have not been established in patients aged 65 years and over (see section 5.2).